200 related articles for article (PubMed ID: 22776466)
1. Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia.
Kuo SC; Lee YT; Yang SP; Chiang MC; Lin YT; Tseng FC; Chen TL; Fung CP
Clin Microbiol Infect; 2013 Jul; 19(7):634-9. PubMed ID: 22776466
[TBL] [Abstract][Full Text] [Related]
2. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection.
Lee YT; Kuo SC; Yang SP; Lin YT; Tseng FC; Chen TL; Fung CP
Clin Infect Dis; 2012 Jul; 55(2):209-15. PubMed ID: 22495546
[TBL] [Abstract][Full Text] [Related]
3. Bacteremic nosocomial pneumonia caused by Acinetobacter baumannii and Acinetobacter nosocomialis: a single or two distinct clinical entities?
Lee YT; Kuo SC; Yang SP; Lin YT; Chiang DH; Tseng FC; Chen TL; Fung CP
Clin Microbiol Infect; 2013 Jul; 19(7):640-5. PubMed ID: 22967204
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and clinical outcome of sulbactam nonsusceptibility in monomicrobial Acinetobacter nosocomialis bacteremia.
Lai HH; Liou BH; Chang YY; Kuo SC; Lee YT; Chen TL; Fung CP
J Microbiol Immunol Infect; 2016 Jun; 49(3):371-7. PubMed ID: 25081987
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure.
Wang YC; Lee YT; Yang YS; Chen CT; Chiu CH; Yin T; Kuo SC; Chen TL; Lin JC; Wang FD; Fung CP; Chang FY
Clin Microbiol Infect; 2015 Aug; 21(8):758-64. PubMed ID: 25980356
[TBL] [Abstract][Full Text] [Related]
6. Comparison between bacteremia caused by Acinetobacter pittii and Acinetobacter nosocomialis.
Liu YM; Lee YT; Kuo SC; Chen TL; Liu CP; Liu CE
J Microbiol Immunol Infect; 2017 Feb; 50(1):62-67. PubMed ID: 25735795
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and prognostic factors of Acinetobacter nosocomialis bacteraemia in patients with solid tumours.
Wu HS; Kuo SC; Lee YT; Yang YS; Cheng SS; Chen TL; Fung CP
Clin Microbiol Infect; 2012 Sep; 18(9):E373-6. PubMed ID: 22712825
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
Huang ST; Chiang MC; Kuo SC; Lee YT; Chiang TH; Yang SP; Ti-Yin ; Chen TL; Fung CP
J Microbiol Immunol Infect; 2012 Oct; 45(5):356-62. PubMed ID: 22575430
[TBL] [Abstract][Full Text] [Related]
9. Influence of severity of infection on the effect of appropriate antimicrobial therapy for Acinetobacter baumannii bacteremic pneumonia.
Kang FY; How CK; Wang YC; Cheng A; Yang YS; Kuo SC; Liu CP; Liu YM; Chen TL; Lee YT
Antimicrob Resist Infect Control; 2020 Sep; 9(1):160. PubMed ID: 32993810
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy.
Falagas ME; Kasiakou SK; Rafailidis PI; Zouglakis G; Morfou P
J Antimicrob Chemother; 2006 Jun; 57(6):1251-4. PubMed ID: 16627593
[TBL] [Abstract][Full Text] [Related]
11. Mortality risk factors of Acinetobacter baumannii bacteraemia.
Choi JY; Park YS; Kim CO; Park YS; Yoon HJ; Shin SY; Kim YA; Song YG; Yong D; Lee K; Kim JM
Intern Med J; 2005 Oct; 35(10):599-603. PubMed ID: 16207259
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii.
Tseng YC; Wang JT; Wu FL; Chen YC; Chie WC; Chang SC
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):181-90. PubMed ID: 17662564
[TBL] [Abstract][Full Text] [Related]
13. Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes.
Lee YC; Huang YT; Tan CK; Kuo YW; Liao CH; Lee PI; Hsueh PR
J Antimicrob Chemother; 2011 Aug; 66(8):1839-46. PubMed ID: 21653602
[TBL] [Abstract][Full Text] [Related]
14. Multicentre study of risk factors for mortality in patients with Acinetobacter bacteraemia receiving colistin treatment.
Lee YT; Sun JR; Wang YC; Chiu CH; Kuo SC; Chen TL; ; Yang YS
Int J Antimicrob Agents; 2020 Jun; 55(6):105956. PubMed ID: 32278810
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.
Anunnatsiri S; Tonsawan P
Southeast Asian J Trop Med Public Health; 2011 May; 42(3):693-703. PubMed ID: 21706949
[TBL] [Abstract][Full Text] [Related]
16. Community-acquired bacteremia at a teaching versus a nonteaching hospital: impact of acute severity of illness on 30-day mortality.
Mylotte JM; Kahler L; McCann C
Am J Infect Control; 2001 Feb; 29(1):13-9. PubMed ID: 11172313
[TBL] [Abstract][Full Text] [Related]
17. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia.
Kwon KT; Oh WS; Song JH; Chang HH; Jung SI; Kim SW; Ryu SY; Heo ST; Jung DS; Rhee JY; Shin SY; Ko KS; Peck KR; Lee NY
J Antimicrob Chemother; 2007 Mar; 59(3):525-30. PubMed ID: 17213265
[TBL] [Abstract][Full Text] [Related]
18. Acinetobacter baumannii bacteraemia in patients with haematological malignancy: a multicentre retrospective study from the Infection Working Party of Jiangsu Society of Hematology.
Wang X; Zhang L; Sun A; Yang X; Sang W; Jiang Y; Cheng J; Wang J; Zhou M; Chen B; Ouyang J
Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1073-1081. PubMed ID: 28101785
[TBL] [Abstract][Full Text] [Related]
19. Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.
Chen CT; Wang YC; Kuo SC; Shih FH; Chen TL; How CK; Yang YS; Lee YT
J Microbiol Immunol Infect; 2018 Oct; 51(5):629-635. PubMed ID: 28701266
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia.
Metan G; Sariguzel F; Sumerkan B
Eur J Intern Med; 2009 Sep; 20(5):540-4. PubMed ID: 19712862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]